Endocrinology and Metabolism (Dec 2020)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis

  • Jonghwa Ahn,
  • Meihua Jin,
  • Eyun Song,
  • Min Ji Jeon,
  • Tae Yong Kim,
  • Jin-Sook Ryu,
  • Won Bae Kim,
  • Young Kee Shong,
  • Ji Min Han,
  • Won Gu Kim

DOI
https://doi.org/10.3803/EnM.2020.747
Journal volume & issue
Vol. 35, no. 4
pp. 830 – 837

Abstract

Read online

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate the clinical impact of the interval between total thyroidectomy (TT) and RRA therapy in patients with low-risk PTC. Methods We included 526 patients who underwent TT and RRA for low-risk PTC with a primary tumor size of >1 cm between 2000 and 2012. Patients were divided into the early (3 months after TT considering other prognostic factors.

Keywords